{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T21:00:12Z","timestamp":1773176412610,"version":"3.50.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2006,3,7]],"date-time":"2006-03-07T00:00:00Z","timestamp":1141689600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2006,4]]},"DOI":"10.1038\/sj.bjc.6603017","type":"journal-article","created":{"date-parts":[[2006,3,7]],"date-time":"2006-03-07T18:44:08Z","timestamp":1141757048000},"page":"1071-1078","source":"Crossref","is-referenced-by-count":35,"title":["Use of antidepressant medications in relation to the incidence of breast cancer"],"prefix":"10.1038","volume":"94","author":[{"given":"D","family":"Fulton-Kehoe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M A","family":"Rossing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"Rutter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M T","family":"Mandelson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N S","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2006,3,7]]},"reference":[{"key":"BF6603017_CR1","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/S0165-0327(97)00086-4","volume":"46","author":"JD Amsterdam","year":"1997","unstructured":"Amsterdam JD, Garcia-Espana F, Goodman D, Hooper M, Hornig-Rohan M (1997) Breast enlargement during chronic antidepressant therapy. J Affect Disord 46: 151\u2013156","journal-title":"J Affect Disord"},{"key":"BF6603017_CR2","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1093\/oxfordjournals.epirev.a036103","volume":"15","author":"CA Bodian","year":"1993","unstructured":"Bodian CA (1993) Benign breast diseases, carcinoma in situ, and breast cancer risk. Epidemiol Rev 15: 177\u2013187","journal-title":"Epidemiol Rev"},{"key":"BF6603017_CR3","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1093\/aje\/kwh038","volume":"159","author":"DM Boudreau","year":"2004","unstructured":"Boudreau DM, Daling JR, Malone KE, Gardner JS, Blough DK, Heckbert SR (2004) A validation study of patient interview data and pharmacy records for antihypertensive, statin, and antidepressant medication use among older women. Am J Epidemiol 159: 308\u2013317","journal-title":"Am J Epidemiol"},{"key":"BF6603017_CR4","unstructured":"Chien C, Li CI, Heckbert SR, Malone KE, Boudreau DM, Daling JR (2005) Antidepressant use and breast cancer risk. Breast Cancer Res Treat 1\u201310"},{"key":"BF6603017_CR5","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1093\/aje\/kwi301","volume":"152","author":"PF Coogan","year":"2005","unstructured":"Coogan PF, Palmer JR, Strom BL, Rosenberg L (2005) Use of selective serotonin reuptake inhibitors and the risk of breast cancer. Am J Epidemiol 152: 835\u2013838","journal-title":"Am J Epidemiol"},{"key":"BF6603017_CR6","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1093\/oxfordjournals.aje.a010138","volume":"151","author":"M Cotterchio","year":"2000","unstructured":"Cotterchio M, Kreiger N, Darlington G, Steingart A (2000) Antidepressant medication use and breast cancer risk. Am J Epidemiol 151: 951\u2013957","journal-title":"Am J Epidemiol"},{"key":"BF6603017_CR7","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1177\/026988119701100410","volume":"11","author":"PJ Cowen","year":"1997","unstructured":"Cowen PJ, Sargent PA (1997) Changes in plasma prolactin during SSRI treatment: evidence for a delayed increase in 5-HT neurotransmission. J Psychopharmacol 11: 345\u2013348","journal-title":"J Psychopharmacol"},{"key":"BF6603017_CR8","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1038\/sj.npp.1300412","volume":"29","author":"AB Emiliano","year":"2004","unstructured":"Emiliano AB, Fudge JL (2004) From galactorrhea to osteopenia: rethinking serotonin-prolactin interactions. Neuropsychopharmacology 29: 833\u2013846","journal-title":"Neuropsychopharmacology"},{"key":"BF6603017_CR9","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1097\/01.ede.0000147103.92638.c0","volume":"16","author":"A Gonzalez-Perez","year":"2005","unstructured":"Gonzalez-Perez A, Garcia Rodriguez LA (2005) Breast cancer risk among users of antidepressant medications. Epidemiology 16: 101\u2013105","journal-title":"Epidemiology"},{"key":"BF6603017_CR10","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1093\/jnci\/91.7.629","volume":"91","author":"SE Hankinson","year":"1999","unstructured":"Hankinson SE, Willett WC, Michaud DS, Manson JE, Colditz GA, Longcope C, Rosner B, Speizer FE (1999) Plasma prolactin levels and subsequent risk of breast cancer in postmenopausal women. J Natl Cancer Inst 91: 629\u2013634","journal-title":"J Natl Cancer Inst"},{"key":"BF6603017_CR11","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.canlet.2004.11.003","volume":"221","author":"R Haque","year":"2005","unstructured":"Haque R, Enger SM, Chen W, Petitti DB (2005) Breast cancer risk in a large cohort of female antidepressant medication users. Cancer Lett 221: 61\u201365","journal-title":"Cancer Lett"},{"key":"BF6603017_CR12","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1097\/00000478-200306000-00015","volume":"27","author":"RA Jensen","year":"2003","unstructured":"Jensen RA, Page DL (2003) Ductal carcinoma in situ of the breast: impact of pathology on therapeutic decisions. Am J Surg Pathol 27: 828\u2013831","journal-title":"Am J Surg Pathol"},{"key":"BF6603017_CR13","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1093\/oxfordjournals.aje.a010091","volume":"150","author":"JP Kelly","year":"1999","unstructured":"Kelly JP, Rosenberg L, Palmer JR, Rao RS, Strom BL, Stolley PD, Zauber AG, Shapiro S (1999) Risk of breast cancer according to use of antidepressants, phenothiazines, and antihistamines. Am J Epidemiol 150: 861\u2013868","journal-title":"Am J Epidemiol"},{"key":"BF6603017_CR14","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s00228-004-0726-3","volume":"60","author":"WE Meijer","year":"2004","unstructured":"Meijer WE, Heerdink ER, Leufkens HG, Herings RM, Egberts AC, Nolen WA (2004) Incidence and determinants of long-term use of antidepressants. Eur J Clin Pharmacol 60: 57\u201361","journal-title":"Eur J Clin Pharmacol"},{"key":"BF6603017_CR15","first-page":"307","volume":"14","author":"PG Moorman","year":"2003","unstructured":"Moorman PG, Grubber JM, Millikan RC, Newman B (2003) Antidepressant medications and their association with invasive breast cancer and carcinoma in situ of the breast. Epidemiology 14: 307\u2013314","journal-title":"Epidemiology"},{"key":"BF6603017_CR16","doi-asserted-by":"publisher","first-page":"153","DOI":"10.4088\/PCC.v05n0402","volume":"5","author":"PA Pirraglia","year":"2003","unstructured":"Pirraglia PA, Stafford RS, Singer DE (2003) Trends in prescribing of selective serotonin reuptake inhibitors and other newer antidepressant agents in adult primary care. Prim Care Companion J Clin Psychiatry 5: 153\u2013157","journal-title":"Prim Care Companion J Clin Psychiatry"},{"key":"BF6603017_CR17","first-page":"171","volume-title":"Pharmacoepidemiology","author":"K Saunders","year":"1994","unstructured":"Saunders K, Stergachis A, Von Korff M (1994) Group Health Cooperative of Puget Sound. In Pharmacoepidemiology, Strom, B.L. (ed) John Wiley & Sons: New York, pp 171\u2013185"},{"key":"BF6603017_CR18","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/sj.bjc.6600013","volume":"86","author":"CR Sharpe","year":"2002","unstructured":"Sharpe CR, Collet JP, Belzile E, Hanley JA, Boivin JF (2002) The effects of tricyclic antidepressants on breast cancer risk. Br J Cancer 86: 92\u201397","journal-title":"Br J Cancer"},{"key":"BF6603017_CR19","doi-asserted-by":"publisher","first-page":"232","DOI":"10.4088\/PCC.v03n0611","volume":"3","author":"RS Stafford","year":"2001","unstructured":"Stafford RS, MacDonald EA, Finkelstein SN (2001) National patterns of medication treatment for depression, 1987\u20132001. Prim Care Companion J Clin Psychiatry 3: 232\u2013235","journal-title":"Prim Care Companion J Clin Psychiatry"},{"key":"BF6603017_CR20","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1093\/ije\/dyg155","volume":"32","author":"A Steingart","year":"2003","unstructured":"Steingart A, Cotterchio M, Kreiger N, Sloan M (2003) Antidepressant medication use and breast cancer risk: a case-control study. Int J Epidemiol 32: 961\u2013966","journal-title":"Int J Epidemiol"},{"key":"BF6603017_CR21","unstructured":"Surveillance, Epidemiology and End Results (SEER) (2005) Available at \n                    http:\/\/www.seer.cancer.gov\n                    \n                  . National Cancer Institute"},{"key":"BF6603017_CR22","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1002\/1097-0142(19900815)66:4<812::AID-CNCR2820660436>3.0.CO;2-1","volume":"66","author":"SH Taplin","year":"1990","unstructured":"Taplin SH, Thompson RS, Schnitzer F, Anderman C, Immanuel V (1990) Revisions in the risk-based Breast Cancer Screening Program at Group Health Cooperative. Cancer 66: 812\u2013818","journal-title":"Cancer"},{"key":"BF6603017_CR23","first-page":"697","volume":"9","author":"A Trentham-Dietz","year":"2000","unstructured":"Trentham-Dietz A, Newcomb PA, Storer BE, Remington PL (2000) Risk factors for carcinoma in situ of the breast. Cancer Epidemiol Biomarkers Prev 9: 697\u2013703","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"BF6603017_CR24","doi-asserted-by":"publisher","first-page":"6814","DOI":"10.1158\/0008-5472.CAN-04-1870","volume":"64","author":"SS Tworoger","year":"2004","unstructured":"Tworoger SS, Eliassen AH, Rosner B, Sluss P, Hankinson SE (2004) Plasma prolactin concentrations and risk of postmenopausal breast cancer. Cancer Res 64: 6814\u20136819","journal-title":"Cancer Res"},{"key":"BF6603017_CR25","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/0165-1218(91)90085-Z","volume":"260","author":"N van Schaik","year":"1991","unstructured":"van Schaik N, Graf U (1991) Genotoxicity evaluation of five tricyclic antidepressants in the wing somatic mutation and recombination test in Drosophila melanogaster. Mutat Res 260: 99\u2013104","journal-title":"Mutat Res"},{"key":"BF6603017_CR26","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/0027-5107(93)90179-J","volume":"286","author":"N van Schaik","year":"1993","unstructured":"van Schaik N, Graf U (1993) Structure-activity relationships of tricyclic antidepressants and related compounds in the wing somatic mutation and recombination test of Drosophila melanogaster. Mutat Res 286: 155\u2013163","journal-title":"Mutat Res"},{"key":"BF6603017_CR27","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/S0895-4356(00)00354-1","volume":"54","author":"PS Wang","year":"2001","unstructured":"Wang PS, Walker AM, Tsuang MT, Orav EJ, Levin R, Avorn J (2001) Antidepressant use and the risk of breast cancer: a non-association. J Clin Epidemiol 54: 728\u2013734","journal-title":"J Clin Epidemiol"},{"key":"BF6603017_CR28","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1038\/bjc.1996.248","volume":"73","author":"HA Weiss","year":"1996","unstructured":"Weiss HA, Brinton LA, Brogan D, Coates RJ, Gammon MD, Malone KE, Schoenberg JB, Swanson CA (1996) Epidemiology of in situ and invasive breast cancer in women aged under 45. Br J Cancer 73: 1298\u20131305","journal-title":"Br J Cancer"},{"key":"BF6603017_CR29","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1093\/oxfordjournals.aje.a117563","volume":"142","author":"SL West","year":"1995","unstructured":"West SL, Savitz DA, Koch G, Strom BL, Guess HA, Hartzema A (1995) Recall accuracy for prescription medications: self-report compared with database information. Am J Epidemiol 142: 1103\u20131112","journal-title":"Am J Epidemiol"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/6603017.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6603017","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6603017.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T12:20:14Z","timestamp":1684412414000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/6603017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,3,7]]},"references-count":29,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2006,4]]}},"alternative-id":["BF6603017"],"URL":"https:\/\/doi.org\/10.1038\/sj.bjc.6603017","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,3,7]]}}}